Korean J Endocr Surg.
2006 Jun;6(1):1-5. 10.16956/kjes.2006.6.1.1.
Bone Mineral Density in Postsurgical Thyroxine Replacement
- Affiliations
-
- 1Department of Surgery, Chonnam National University Medical School, Gwangju, Korea. thokthok@hanmail.net
- KMID: 2383013
- DOI: http://doi.org/10.16956/kjes.2006.6.1.1
Abstract
- PURPOSE
Bone turnover is increased in patients suffering with hyperthyroidism, and this results in osteoporosis. Especially after total thyroidectomy for the treatment of thyroid papillary cancer, it is necessary to pay attention to osteoporosis because we must treat these patients with suppressive thyroxine therapy.
METHODS
Among the patients who underwent endocrine surgery of Chonnam National University, 110 cases had taken thyroxine for more than one year. We analyzed them on the basis of their medical record. The study consisted of women between 45 and 74 years of age who were treated with thyroxine for more than one year, who had total thyroidectomy performed for thyroid papillary carcinoma and who taken thyroxine for 12~142 months (mean: 53 months). We measured the bone mineral density at the lumbar spine and the femoral neck with using dual energy X-ray absorptiometry.
RESULTS
The bone mineral density of the lumbar spine and femur neck was significantly reduced with the increasing the duration of thyroxine medication. Yet this was not significant after adjusting by age. There was correlation between the TSH levels and bone mineral densities.
CONCLUSION
After total thyroidectomy, it may be necessary to evaluate the bone mineral density of the patients who were treated with suppressive thyroxine and also to warn them about osteoporosis.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Estrogen Replacement Therapy Continuously Combined with Progesterone; Effect on Bone Mineral Density and Lipid Metabolism
- Decreased axial bone density in postmenopausal patients with subclinical hyperthyroidism as a result of suppressive thyroxine therapy
- The Effect of Hormone Replacement Therapy on Biochemical Markers of Bone Turnover in Postmenopausal Women
- Long-Term Effects of Oral Progesterone (Medroxyprogesterone Acetate) on the Level of Bone Mineral Density During Estrogen Replacement Therapy in Postmenopausal Women
- The relationship of maturation value of vaginal epithelium and bone mineral density in postmenopausal women
